245 related articles for article (PubMed ID: 24437489)
1. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.
Kim DH; Zhang T; Lee S; Calabuig-Navarro V; Yamauchi J; Piccirillo A; Fan Y; Uppala R; Goetzman E; Dong HH
Endocrinology; 2014 Apr; 155(4):1255-67. PubMed ID: 24437489
[TBL] [Abstract][Full Text] [Related]
2. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.
Kamagate A; Qu S; Perdomo G; Su D; Kim DH; Slusher S; Meseck M; Dong HH
J Clin Invest; 2008 Jun; 118(6):2347-64. PubMed ID: 18497885
[TBL] [Abstract][Full Text] [Related]
3. FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
Kim DH; Perdomo G; Zhang T; Slusher S; Lee S; Phillips BE; Fan Y; Giannoukakis N; Gramignoli R; Strom S; Ringquist S; Dong HH
Diabetes; 2011 Nov; 60(11):2763-74. PubMed ID: 21940782
[TBL] [Abstract][Full Text] [Related]
4. FoxO1 integrates insulin signaling to VLDL production.
Kamagate A; Dong HH
Cell Cycle; 2008 Oct; 7(20):3162-70. PubMed ID: 18927507
[TBL] [Abstract][Full Text] [Related]
5. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
6. Overindulgence and metabolic syndrome: is FoxO1 a missing link?
Sparks JD; Sparks CE
J Clin Invest; 2008 Jun; 118(6):2012-5. PubMed ID: 18497882
[TBL] [Abstract][Full Text] [Related]
7. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis.
Spann NJ; Kang S; Li AC; Chen AZ; Newberry EP; Davidson NO; Hui ST; Davis RA
J Biol Chem; 2006 Nov; 281(44):33066-77. PubMed ID: 16950764
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
[TBL] [Abstract][Full Text] [Related]
9. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.
Tietge UJ; Bakillah A; Maugeais C; Tsukamoto K; Hussain M; Rader DJ
J Lipid Res; 1999 Nov; 40(11):2134-9. PubMed ID: 10553017
[TBL] [Abstract][Full Text] [Related]
10. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise training on hepatic microsomal triglyceride transfer protein content in rats.
Chapados NA; Seelaender M; Levy E; Lavoie JM
Horm Metab Res; 2009 Apr; 41(4):287-93. PubMed ID: 19023847
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
López-Parra M; Titos E; Horrillo R; Ferré N; González-Périz A; Martínez-Clemente M; Planagumà A; Masferrer J; Arroyo V; Clària J
J Lipid Res; 2008 Dec; 49(12):2513-23. PubMed ID: 18645210
[TBL] [Abstract][Full Text] [Related]
13. miR-130b is a potent stimulator of hepatic very-low-density lipoprotein assembly and secretion via marked induction of microsomal triglyceride transfer protein.
Zhang J; Jazii FR; Haghighi MM; Alvares D; Liu L; Khosraviani N; Adeli K
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E262-E275. PubMed ID: 31821038
[TBL] [Abstract][Full Text] [Related]
14. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
15. Assembly and secretion of VLDL in nondifferentiated Caco-2 cells stably transfected with human recombinant ApoB48 cDNA.
Luchoomun J; Zhou Z; Bakillah A; Jamil H; Hussain MM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2955-63. PubMed ID: 9409282
[TBL] [Abstract][Full Text] [Related]
16. The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes.
Mason TM
Crit Rev Clin Lab Sci; 1998 Dec; 35(6):461-87. PubMed ID: 9885772
[TBL] [Abstract][Full Text] [Related]
17. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
18. Targeting FoxO1 for hypertriglyceridemia.
Kim DH; Zhang T; Ringquist S; Dong HH
Curr Drug Targets; 2011 Aug; 12(9):1245-55. PubMed ID: 21443465
[TBL] [Abstract][Full Text] [Related]
19. Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet.
van Diepen JA; Vroegrijk IO; Berbée JF; Shoelson SE; Romijn JA; Havekes LM; Rensen PC; Voshol PJ
Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1099-107. PubMed ID: 21862721
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatic insulin expression on lipid metabolism in diabetic mice.
Qu S; Zhang T; Dong HH
J Diabetes; 2016 May; 8(3):314-23. PubMed ID: 25851734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
